YS Biopharma (NASDAQ:YS) Stock Price Up 5.3%

YS Biopharma Co., Ltd. (NASDAQ:YS) shares rose 5.3% during trading on Monday . The company traded as high as $0.65 and last traded at $0.65. 1,954 shares changed hands during trading, a decline of 99% from the average daily volume of 172,401 shares. The stock had previously closed at $0.62.

YS Biopharma Price Performance

The company has a quick ratio of 0.73, a current ratio of 0.94 and a debt-to-equity ratio of 0.26. The company’s fifty day moving average price is $0.82 and its 200 day moving average price is $0.66.

Institutional Trading of YS Biopharma

A hedge fund recently bought a new stake in YS Biopharma stock. Superstring Capital Management LP purchased a new position in shares of YS Biopharma Co., Ltd. (NASDAQ:YS) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 307,920 shares of the company’s stock, valued at approximately $166,000. Superstring Capital Management LP owned 0.33% of YS Biopharma as of its most recent filing with the SEC. 52.64% of the stock is owned by institutional investors and hedge funds.

About YS Biopharma

YS Biopharma Co, Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001.